Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Innovative Health Commits to Ambitious 2030 Greenhouse Gas Reduction Goal
10/24/2024
The reprocessing company seeks to further improve its already impressive impact on greenhouse gas emissions in healthcare
The reprocessing company seeks to further improve its already impressive impact on greenhouse gas emissions in healthcare
The reprocessing company seeks...
10/24/2024
EP Lab Digest

Advertisement

News
Catheter Precision Announces Clinical Publication of Non-Invasive Stereotactic Radioablation Using VIVO
10/22/2024
Catheter Precision Press Release  FORT MILL, SC / October 21, 2024 / Catheter Precision, Inc. (NYSE American:VTAK), a US based medical device company focused on developing technologically advanced products for the cardiac...
Catheter Precision Press Release  FORT MILL, SC / October 21, 2024 / Catheter Precision, Inc. (NYSE American:VTAK), a US based medical device company focused on developing technologically advanced products for the cardiac...
Catheter Precision Press...
10/22/2024
EP Lab Digest
News
Philips Showcases Next Level Cardiology Innovations for Improved Patient Care at TCT 2024
10/21/2024
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment for...
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment for...
Philips portfolio of...
10/21/2024
EP Lab Digest
News
Heart Rhythm Society Establishes New Advocacy Organization to Address the Needs of Electrophysiologists and Their Patients
10/18/2024
The Heart Rhythm Society (HRS) Board of Trustees unanimously approved the formation of Heart Rhythm Advocates, a new, shared vision, cause-related nonprofit 501(c)(4) advocacy organization to complement the primary 501(c)(3) nonprofit...
The Heart Rhythm Society (HRS) Board of Trustees unanimously approved the formation of Heart Rhythm Advocates, a new, shared vision, cause-related nonprofit 501(c)(4) advocacy organization to complement the primary 501(c)(3) nonprofit...
The Heart Rhythm Society (HRS)...
10/18/2024
EP Lab Digest

Advertisement

News
Tenaya Therapeutics Announces Updates on TN-201 Gene Therapy Program for MYBPC3-associated HCM
10/18/2024
Tenaya Therapeutics Press Release SOUTH SAN FRANCISCO, Calif., Oct. 17, 2024 -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies...
Tenaya Therapeutics Press Release SOUTH SAN FRANCISCO, Calif., Oct. 17, 2024 -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies...
Tenaya Therapeutics Press...
10/18/2024
EP Lab Digest
News
Boston Scientific Launches Next Generation of Cardiac Mapping for the FARAPULSE™ Pulsed Field Ablation System
10/18/2024
Boston Scientific Press Release  MARLBOROUGH, Mass., Oct. 18, 2024 -- Boston Scientific Corporation (NYSE: BSX) today announced it has received U.S. Food and Drug Administration (FDA) approval for the navigation-enabled...
Boston Scientific Press Release  MARLBOROUGH, Mass., Oct. 18, 2024 -- Boston Scientific Corporation (NYSE: BSX) today announced it has received U.S. Food and Drug Administration (FDA) approval for the navigation-enabled...
Boston Scientific Press...
10/18/2024
EP Lab Digest
News
XYRA Announces FDA Label Guidance for Managing Atrial Fibrillation with Budiodarone and Wearable Monitoring Devices
10/17/2024
XYRA Press Release  Key points: Wearable AF monitoring devices are extensively used in routine practice worldwide. The FDA has agreed on the use of AF monitoring devices in clinical trials for budiodarone approval. The FDA...
XYRA Press Release  Key points: Wearable AF monitoring devices are extensively used in routine practice worldwide. The FDA has agreed on the use of AF monitoring devices in clinical trials for budiodarone approval. The FDA...
XYRA Press Release  Key...
10/17/2024
EP Lab Digest

Advertisement

News
Heart Failure, Atrial Fibrillation, and Coronary Heart Disease Linked to Cognitive Impairment
10/17/2024
Three common cardiovascular diseases in adults—heart failure, atrial fibrillation and coronary heart disease—are linked to cognitive impairment and increased risk of dementia, according to “Cardiac Contributions to Brain Health,” a new...
Three common cardiovascular diseases in adults—heart failure, atrial fibrillation and coronary heart disease—are linked to cognitive impairment and increased risk of dementia, according to “Cardiac Contributions to Brain Health,” a new...
Three common cardiovascular...
10/17/2024
EP Lab Digest
News
AtriCure Announces Launch of cryoSPHERE MAX™ Probe for Post-Operative Pain Management
10/17/2024
AtriCure Press Release  MASON, Ohio -- AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain...
AtriCure Press Release  MASON, Ohio -- AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain...
AtriCure Press...
10/17/2024
EP Lab Digest
News
Thryv Therapeutics Receives Positive Top-Line Results from Wave I Part 2 Clinical Study in Long QT Syndrome Type 2 and Type 3 Patients
10/17/2024
Thryv Therapeutics Press Release  MONTREAL, Oct. 15, 2024 - Thryv Therapeutics Inc., a clinical-stage biotechnology company, received positive top-line results from the Wave I Part 2 proof-of-concept clinical study...
Thryv Therapeutics Press Release  MONTREAL, Oct. 15, 2024 - Thryv Therapeutics Inc., a clinical-stage biotechnology company, received positive top-line results from the Wave I Part 2 proof-of-concept clinical study...
Thryv Therapeutics Press...
10/17/2024
EP Lab Digest

Advertisement

Advertisement

EPLD November 2024 cover

Current Issue

November 2024
Volume 24
Issue 11
Current Issue
Issue Archive

Advertisement

Advertisement

Stay in the know.

EP Lab Digest Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use